Ligand validation:4C3Y

FAD: FLAVIN-ADENINE DINUCLEOTIDE

FAD is a Ligand Of Interest in 4C3Y designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4C3Y_FAD_D_551	84%	15%	0.104	0.965	1.94	1.84	13	15	2	0	100%	1
4C3Y_FAD_B_551	83%	17%	0.115	0.975	1.85	1.75	12	17	2	0	100%	1
4C3Y_FAD_C_551	83%	14%	0.108	0.967	1.94	1.9	14	17	1	0	100%	1
4C3Y_FAD_G_551	81%	18%	0.12	0.971	2.03	1.54	11	10	1	0	100%	1
4C3Y_FAD_F_551	80%	20%	0.118	0.968	1.6	1.75	8	14	1	0	100%	1
4C3Y_FAD_E_551	80%	11%	0.116	0.965	2.37	1.79	9	15	1	0	100%	1
4C3Y_FAD_H_551	79%	16%	0.122	0.969	1.83	1.85	13	16	3	0	100%	1
4C3Y_FAD_A_551	78%	16%	0.122	0.965	1.95	1.75	11	10	1	0	100%	1
4C3X_FAD_G_551	93%	18%	0.085	0.979	1.79	1.76	14	12	2	0	100%	1
8KCZ_FAD_A_601	70%	56%	0.155	0.973	0.69	0.99	-	3	1	0	100%	1
8JBZ_FAD_AAA_601	54%	68%	0.169	0.936	0.59	0.66	-	2	5	0	100%	1
8JU4_FAD_A_601	54%	56%	0.209	0.976	0.69	0.99	-	3	1	0	100%	1
8JOJ_FAD_A_601	38%	58%	0.274	0.977	0.69	0.91	1	3	9	0	100%	1
2R4J_FAD_B_600	100%	13%	0.024	0.995	2	1.99	18	19	0	0	100%	1
4KGD_FAD_B_701	100%	45%	0.031	0.997	1.1	1.03	2	2	0	0	100%	1
4PVH_FAD_A_601	100%	35%	0.028	0.993	1.32	1.23	7	7	2	0	100%	1
4PVK_FAD_A_601	100%	43%	0.026	0.995	1.12	1.07	4	2	0	0	100%	1
4FEG_FAD_B_710	100%	38%	0.033	0.997	1.25	1.2	4	5	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.